抗菌药物对从癌症患者中分离出的栖稻黄单胞菌临床分离株的体外活性。
In vitro activities of antimicrobial agents against clinical isolates of Flavimonas oryzihabitans obtained from patients with cancer.
作者信息
Rolston K V, Ho D H, LeBlanc B, Bodey G P
机构信息
Department of Medical Specialties, University of Texas M.D. Anderson Cancer Center, Houston 77030.
出版信息
Antimicrob Agents Chemother. 1993 Nov;37(11):2504-5. doi: 10.1128/AAC.37.11.2504.
Abstract
We evaluated the in vitro activities of 21 different antimicrobial agents against nine clinical isolates of Flavimonas oryzihabitans obtained from patients with cancer. The organisms were susceptible to most agents commonly used for the empiric therapy (aminoglycosides, ureidopenicillins, extended-spectrum cephalosporins, monobactams, and carbapenems) and prevention of infections (quinolones and trimethoprim-sulfamethoxazole) in this patient population.
摘要
我们评估了21种不同抗菌药物对从癌症患者中分离出的9株栖稻黄单胞菌临床菌株的体外活性。在该患者群体中，这些菌株对常用于经验性治疗（氨基糖苷类、脲基青霉素、广谱头孢菌素、单环β-内酰胺类和碳青霉烯类）及预防感染（喹诺酮类和甲氧苄啶-磺胺甲恶唑）的大多数药物敏感。
相似文献
1
In vitro activities of antimicrobial agents against clinical isolates of Flavimonas oryzihabitans obtained from patients with cancer.抗菌药物对从癌症患者中分离出的栖稻黄单胞菌临床分离株的体外活性。
Antimicrob Agents Chemother. 1993 Nov;37(11):2504-5. doi: 10.1128/AAC.37.11.2504.
2
Flavimonas oryzihabitans bacteremia: clinical features and microbiological characteristics of isolates.栖稻黄单胞菌血症：分离株的临床特征与微生物学特性
Clin Infect Dis. 1997 May;24(5):867-73. doi: 10.1093/clinids/24.5.867.
3
Unusual clinical presentation of infection due to Flavimonas oryzihabitans.栖稻黄色单胞菌感染的不寻常临床表现。
Eur J Clin Microbiol Infect Dis. 1998 Sep;17(9):645-8. doi: 10.1007/BF01708348.
4
In vitro susceptibility of Xanthomonas (Pseudomonas) maltophilia to newer antimicrobial agents.嗜麦芽窄食单胞菌（假单胞菌）对新型抗菌药物的体外敏感性
Antimicrob Agents Chemother. 1990 Aug;34(8):1609-10. doi: 10.1128/AAC.34.8.1609.
5
Bacteraemia and sinusitis due to Flavimonas oryzihabitans infection.嗜稻黄单胞菌感染所致菌血症和鼻窦炎
Scand J Infect Dis. 2003;35(6-7):411-4. doi: 10.1080/00365540310012208.
6
In vitro susceptibilities of tropical strains of Aeromonas species from Queensland, Australia, to 22 antimicrobial agents.来自澳大利亚昆士兰的嗜水气单胞菌热带菌株对22种抗菌剂的体外敏感性
Antimicrob Agents Chemother. 1993 Apr;37(4):905-7. doi: 10.1128/AAC.37.4.905.
7
[A case of urinary tract infection caused by Flavimonas oryzihabitans].[一株栖稻黄色单胞菌引起的尿路感染病例]
Mikrobiyol Bul. 2007 Jan;41(1):133-7.
8
Infections caused by Flavimonas oryzihabitans.栖稻黄单胞菌引起的感染。
Chin Med J (Engl). 2001 Apr;114(4):394-8.
9
In vitro susceptibilities of Pseudomonas pseudomallei to 27 antimicrobial agents.类鼻疽杆菌对27种抗菌药物的体外敏感性
Antimicrob Agents Chemother. 1990 Oct;34(10):2027-9. doi: 10.1128/AAC.34.10.2027.
10
Comparison of antimicrobial use and resistance of bacterial isolates in a haematology ward and an intensive care unit.血液科病房与重症监护病房细菌分离株抗菌药物使用情况及耐药性比较。
Eur J Clin Microbiol Infect Dis. 2001 Sep;20(9):657-60. doi: 10.1007/s100960100582.
引用本文的文献
1
A rare cause of peritonitis caused by Flavimonas oryzihabitans in continuous ambulatory peritoneal dialysis (CAPD).在持续性非卧床腹膜透析（CAPD）中，由栖稻黄单胞菌引起的腹膜炎的罕见病因。
Int Urol Nephrol. 2005;37(2):433-6. doi: 10.1007/s11255-004-4650-3.
2
Haemorrhagic papular rash associated to Flavimonas oryzihabitans bacteraemia in a child.一名儿童中与栖稻黄单胞菌菌血症相关的出血性丘疹皮疹
Eur J Epidemiol. 2000 Mar;16(3):277-9. doi: 10.1023/a:1007686706729.
3
Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rods.曲伐沙星单独及与其他药物联合应用对革兰阴性非发酵菌的比较活性
Antimicrob Agents Chemother. 1997 Jul;41(7):1475-81. doi: 10.1128/AAC.41.7.1475.
4
Susceptibilities of non-Pseudomonas aeruginosa gram-negative nonfermentative rods to ciprofloxacin, ofloxacin, levofloxacin, D-ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, and imipenem.非铜绿假单胞菌革兰氏阴性非发酵菌对环丙沙星、氧氟沙星、左氧氟沙星、D-氧氟沙星、司帕沙星、头孢他啶、哌拉西林、哌拉西林-他唑巴坦、甲氧苄啶-磺胺甲恶唑和亚胺培南的敏感性。
Antimicrob Agents Chemother. 1996 Mar;40(3):772-5. doi: 10.1128/AAC.40.3.772.
本文引用的文献
1
In vitro susceptibilities of nonfermentative gram-negative bacilli other than Pseudomonas aeruginosa to 32 antimicrobial agents.除铜绿假单胞菌外的非发酵革兰氏阴性杆菌对32种抗菌药物的体外敏感性
Rev Infect Dis. 1980 Nov-Dec;2(6):841-53. doi: 10.1093/clinids/2.6.841.
2
Flavimonas oryzihabitans (Pseudomonas oryzihabitans; CDC group Ve-2): an emerging pathogen in peritonitis related to continuous ambulatory peritoneal dialysis?栖稻黄单胞菌（栖稻假单胞菌；疾病控制与预防中心Ve-2组）：是持续性非卧床腹膜透析相关性腹膜炎中的一种新兴病原体吗？
J Clin Microbiol. 1989 Jan;27(1):217-8. doi: 10.1128/jcm.27.1.217-218.1989.
3
Flavimonas oryzihabitans (formerly CDC group Ve-2) bacteremia in a pediatric patient on assisted ventilation.一名接受辅助通气的儿科患者发生栖稻黄单胞菌（原疾病控制与预防中心Ve-2组）菌血症。
Eur J Clin Microbiol Infect Dis. 1990 Oct;9(10):786-8. doi: 10.1007/BF02184698.
4
Flavimonas oryzihabitans septicaemia in a T-cell leukaemic child: a case report and review of the literature.一名患T细胞白血病儿童的栖稻黄单胞菌败血症：病例报告及文献综述
J Infect. 1990 Mar;20(2):135-41. doi: 10.1016/0163-4453(90)93366-z.
5
Isolation of Flavimonas oryzihabitans (CDC group Ve-2) from catheter-induced bacteremia in an immunocompromised patient.从一名免疫功能低下患者的导管相关性菌血症中分离出栖稻黄单胞菌（CDC Ve-2组）。
Eur J Epidemiol. 1990 Dec;6(4):436-7. doi: 10.1007/BF00151722.
6
Flavimonas oryzihabitans infection of a surgical wound.
Pathology. 1990 Oct;22(4):230-1. doi: 10.3109/00313029009086668.
7
Serious infections involving the CDC group Ve bacteria Chryseomonas luteola and Flavimonas oryzihabitans.涉及美国疾病控制与预防中心（CDC）Ve菌群细菌——栖稻黄色单胞菌和栖稻黄单胞菌的严重感染。
Rev Infect Dis. 1991 Mar-Apr;13(2):257-60. doi: 10.1093/clinids/13.2.257.
8
Infections with Chryseomonas luteola (CDC group Ve-1) and Flavimonas oryzihabitans (CDC group Ve-2) in neurosurgical patients.神经外科患者感染栖稻黄色单胞菌（CDC 组 Ve-1）和栖稻黄单胞菌（CDC 组 Ve-2）。
Rev Infect Dis. 1991 Mar-Apr;13(2):233-6. doi: 10.1093/clinids/13.2.233.
9
Flavimonas oryzihabitans (Pseudomonas oryzihabitans; CDC group Ve-2) bacteremia in the immunocompromised host.免疫功能低下宿主中的栖稻黄单胞菌（栖稻假单胞菌；疾病控制与预防中心Ve-2组）菌血症
Arch Intern Med. 1991 Mar;151(3):603-4.
10
In vitro activity of Ro 23-9424, a dual-action antibacterial agent, against bacterial isolates from cancer patients compared with those of other agents.双效抗菌剂Ro 23-9424对癌症患者分离出的细菌的体外活性与其他药剂的比较。
Antimicrob Agents Chemother. 1992 Apr;36(4):879-82. doi: 10.1128/AAC.36.4.879.
Zotero 插件